Austin Regional Clinic

Austin, Texas 78759

1 studies enrolling now · 39 studies all time

What they study most

All Minor Hand Surgery Including, All Orthopedic Disorders, Ankylosing Spondyloarthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Carpal Tunnel Syndrome, Chronic Gout, Colo-rectal Cancer, Colorectal Cancer, Colorectal Cancer Screening, De Quervain Syndrome, Diabetes Mellitus, Type 1

Studies at this site

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. — Recruiting now
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
• Screening for High Frequency Malignant Disease — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis — Completed
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis — Running, not enrolling
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) — Completed
• Nylon Versus Chromic Gut Sutures for Minor Hand Surgery — Completed
• Disjunction Between Patient Narrative and Formulaic Thinking in the Doctor — Withdrawn before enrolling
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis — Completed
• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) — Completed
• Gan & Lee Insulin Glargine Target Type (2) Evaluating Research — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now — Completed
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC. — Completed
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis — Completed
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis — Stopped early
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01) — Stopped early
• A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval — Completed
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. — Completed
• Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro — Withdrawn before enrolling
• Cost Information on Carpal Tunnel Syndrome Treatment Decisions — Completed
• Decision Aids Upper and Lower Extremity — Completed
• Patient Satisfaction Scales — Completed
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis — Completed
• Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab — Completed